← Back to Clinical Trials
Recruiting NCT06024304

NCT06024304 InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06024304
Status Recruiting
Phase
Sponsor Paul E. Matuszewski
Condition Fracture of Hip
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-04-18
Primary Completion 2027-01-01

Trial Parameters

Condition Fracture of Hip
Sponsor Paul E. Matuszewski
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 55 Years
Max Age N/A
Start Date 2025-04-18
Completion 2027-01-01
Interventions
Synthes TFNATrigen InterTAN

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this pilot, patient blinded randomized trial is to develop a mechanistic understanding of gait following fixation of unstable intertrochanteric hip fractures and return to function and pain control. The guiding hypothesis that will be tested in a subsequent clinical trial is that the InterTAN when compared to standard lag-screw cephalomedullary nails will have decreased post operative pain, earlier return to symmetric weight bearing, and quicker return to pre-injury functioning levels.

Eligibility Criteria

Inclusion Criteria: * Non-pathologic fractures * OTA/AO classification 31A2, 31A3 fractures * Ability to participate in 4-MET equivalent activities without ambulatory assistance prior to injury Exclusion Criteria: * Inability to consent * Inability to participate in follow-up activities * History of chronic pain / current opioid treatment * Pre-injury ambulatory status requiring assistance device * Neurological condition altering gait or sensation (e.g. History of stroke with altered gait, peripheral neuropathy).

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology